270 related articles for article (PubMed ID: 33266081)
21. Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281229
[TBL] [Abstract][Full Text] [Related]
22. An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.
DeVoss JJ; LeClair NP; Hou Y; Grewal NK; Johannes KP; Lu W; Yang T; Meagher C; Fong L; Strauss EC; Anderson MS
J Immunol; 2010 Apr; 184(8):4236-46. PubMed ID: 20237294
[TBL] [Abstract][Full Text] [Related]
23. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune Epithelitis and Chronic Inflammation in Sjögren's Syndrome-Related Dry Eye Disease.
Ogawa Y; Takeuchi T; Tsubota K
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769250
[TBL] [Abstract][Full Text] [Related]
26. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
27. A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682784
[TBL] [Abstract][Full Text] [Related]
28. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.
Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA
Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665
[TBL] [Abstract][Full Text] [Related]
29. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
30. Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.
Yoon KC; De Paiva CS; Qi H; Chen Z; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
J Autoimmun; 2008 Jun; 30(4):212-21. PubMed ID: 17988834
[TBL] [Abstract][Full Text] [Related]
31. Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca.
de Paiva CS; Trujillo-Vargas CM; Schaefer L; Yu Z; Britton RA; Pflugfelder SC
Front Immunol; 2021; 12():702755. PubMed ID: 34349764
[TBL] [Abstract][Full Text] [Related]
32. Novel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomia.
Applbaum E; Lichtbroun A
Autoimmun Rev; 2019 Feb; 18(2):199-202. PubMed ID: 30572137
[TBL] [Abstract][Full Text] [Related]
33. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome.
Li H; Dai M; Zhuang Y
Immunity; 2004 Oct; 21(4):551-60. PubMed ID: 15485632
[TBL] [Abstract][Full Text] [Related]
34. Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.
Zang S; Cui Y; Cui Y; Fei W
Eye (Lond); 2018 Nov; 32(11):1681-1687. PubMed ID: 29934634
[TBL] [Abstract][Full Text] [Related]
35. Clinical and immunological parameters of Sjögren's syndrome.
Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A
Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041
[TBL] [Abstract][Full Text] [Related]
36. Establishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndrome.
McNamara NA; Gallup M; Porco TC
Invest Ophthalmol Vis Sci; 2014 Sep; 55(11):7079-84. PubMed ID: 25228544
[TBL] [Abstract][Full Text] [Related]
37. Mouse Models of Primary Sjogren's Syndrome.
Park YS; Gauna AE; Cha S
Curr Pharm Des; 2015; 21(18):2350-64. PubMed ID: 25777752
[TBL] [Abstract][Full Text] [Related]
38. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
[TBL] [Abstract][Full Text] [Related]
39. Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren's syndrome.
Xuan J; Shen L; Malyavantham K; Pankewycz O; Ambrus JL; Suresh L
BMC Oral Health; 2013 Oct; 13():51. PubMed ID: 24093879
[TBL] [Abstract][Full Text] [Related]
40. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
